Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Anouar Abidi, Nadia Kourda, Moncef Feki & Saloua Ben Khamsa. (2020) Protective Effect of Tunisian Flaxseed Oil against Bleomycin-Induced Pulmonary Fibrosis in Rats. Nutrition and Cancer 72:2, pages 226-238.
Read now
Read now
Chloé Rancoule, Jean-Philippe Pradère, Julien Gonzalez, Julie Klein, Philippe Valet, Jean-Loup Bascands, Joost P Schanstra & Jean-Sébastien Saulnier-Blache. (2011) Lysophosphatidic acid-1-receptor targeting agents for fibrosis. Expert Opinion on Investigational Drugs 20:5, pages 657-667.
Read now
Read now
Articles from other publishers (19)
Dilip Kumar Chanchal, Kuldeep Singh, Bharat Bhushan, Jitendra Singh Chaudhary, Shivendra Kumar, Ajit Kumar Varma, Neha Agnihotri & Akash Garg. (2023) An updated review of Chinese skullcap (Scutellaria baicalensis): Emphasis on phytochemical constituents and pharmacological attributes. Pharmacological Research - Modern Chinese Medicine 9, pages 100326.
Crossref
Crossref
Amy Hajari Case, Scott Beegle, David L Hotchkin, Thomas Kaelin, Hyun Joo Kim, Anna J Podolanczuk, Murali Ramaswamy, Carlos Remolina, Mary M Salvatore, Conan Tu & Joao A de Andrade. (2023) Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey. BMJ Open Respiratory Research 10:1, pages e001594.
Crossref
Crossref
Mengyao Xie, Lehe Yang, Jiayun Cheng, Hongyan Qu, Yanting Gu, Cheng Ding, Xiaomei Xu, Chengguang Zhao, Xiaoying Huang & Liangxing Wang. (2023) Gracillin relieves pulmonary fibrosis by suppressing the STAT3 axis. Journal of Ethnopharmacology 316, pages 116704.
Crossref
Crossref
Arturo J Martí-Carvajal, Juan Bautista De Sanctis, Ricardo Hidalgo, Cristina Elena Martí-Amarista, Eduardo Alegría, Andrea Correa-Pérez, Diana Monge Martín & Ricardo J Riera Lizardo. (2022) Colchicine for the primary prevention of cardiovascular events. Cochrane Database of Systematic Reviews 2022:6.
Crossref
Crossref
Taryn B. Hogan, Nivedita Tiwari, M.R. Nagaraja, Shwetha K. Shetty, Liang Fan, Rashmi S. Shetty, Yashodhar P. Bhandary & Sreerama Shetty. (2022) Caveolin-1 peptide regulates p53-microRNA-34a feedback in fibrotic lung fibroblasts. iScience 25:4, pages 104022.
Crossref
Crossref
Michael W. Gill, Brian J. Murphy, Peter T.W. Cheng, Lakshmi Sivaraman, Myrtle Davis & Lois Lehman-McKeeman. (2022) Mechanism of hepatobiliary toxicity of the LPA1 antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: Contrasts with BMS-986234 and BMS-986278. Toxicology and Applied Pharmacology 438, pages 115885.
Crossref
Crossref
L. Sivaraman, M. Gill, D.M. Nelson & K.D. Chadwick. (2022) Structure dependence and species sensitivity of in vivo hepatobiliary toxicity with lysophosphatidic acid receptor 1 (LPA1) antagonists. Toxicology and Applied Pharmacology 438, pages 115846.
Crossref
Crossref
I. N. Mikhaylova, N. M. Treshalina, I. Zh. Shubina, I. V. Manina, M. V. Kiselevsky & A. N. Lukashev. (2021) Antitumor proteinkinase inhibitor imatinib may be regarded as a potential correcting agent for COVID-19 associated pulmonary fibrosis. Advances in Molecular Oncology 7:4, pages 20-28.
Crossref
Crossref
Yuzhen Hu, Miao Li, Mengmeng Zhang & Yiguang Jin. (2018) Inhalation treatment of idiopathic pulmonary fibrosis with curcumin large porous microparticles. International Journal of Pharmaceutics 551:1-2, pages 212-222.
Crossref
Crossref
Scott M. Palmer, Laurie Snyder, Jamie L. Todd, Benjamin Soule, Rose Christian, Kevin Anstrom, Yi Luo, Robert Gagnon & Glenn Rosen. (2018) Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis. Chest 154:5, pages 1061-1069.
Crossref
Crossref
Anouar Abidi, Raja Serairi, Nadia Kourda, Ridha Ben Ali, Saloua Ben Khamsa & Moncef Feki. (2016) Therapeutic effect of flaxseed oil on experimental pulmonary fibrosis induced by bleomycin in rats. European Journal of Inflammation 14:2, pages 133-143.
Crossref
Crossref
Ae Rin BaekJi Min LeeHyun Jung SeoJong Sook ParkJune Hyuk LeeSung Woo ParkAn Soo JangDo Jin KimEun Suk KohSoo Taek UhYong Hoon KimChoon Sik Park. (2016) Apolipoprotein A1 Inhibits TGF-β1–Induced Epithelial-to-Mesenchymal Transition of Alveolar Epithelial Cells. Tuberculosis and Respiratory Diseases 79:3, pages 143.
Crossref
Crossref
Tong GuoKa Yee Lok, Changhe Yu & Zhuo Li. (2014) Lung Fibrosis: Drug Screening and Disease Biomarker Identification with a Lung Slice Culture Model and Subtracted cDNA Library. Alternatives to Laboratory Animals 42:4, pages 235-243.
Crossref
Crossref
Jeffrey R Crawford, Darrell Pilling & Richard H Gomer. (2012) FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation. Journal of Leukocyte Biology 92:4, pages 699-711.
Crossref
Crossref
Blanca E. Alcántar-Díaz, Belinda C. Gómez-Meda, Guillermo M. Zúñiga-González, Ana L. Zamora-Perez, Jaime González-Cuevas, Bertha A. Álvarez-Rodríguez, María Guadalupe Sánchez-Parada, Jesús J. García-Bañuelos & Juan Armendáriz-Borunda. (2012) Genotoxic evaluation of pirfenidone using erythrocyte rodent micronucleus assay. Food and Chemical Toxicology 50:8, pages 2760-2765.
Crossref
Crossref
R. Bucala. (2012) Review Series - Inflammation & Fibrosis * Fibrocytes and fibrosis. QJM 105:6, pages 505-508.
Crossref
Crossref
XM Zhou. (2012) Preventive effects of Citrus reticulata essential oil on bleomycin-induced pulmonary fibrosis in rats and the mechanism. Journal of Chinese Integrative Medicine 10:2, pages 200-209.
Crossref
Crossref
Véronique Plantevin Krenitsky, Lisa Nadolny, Mercedes Delgado, Leticia Ayala, Steven S. Clareen, Robert Hilgraf, Ronald Albers, Sayee Hegde, Neil D’Sidocky, John Sapienza, Jonathan Wright, Meg McCarrick, Sogole Bahmanyar, Philip Chamberlain, Silvia L. Delker, Jeff Muir, David Giegel, Li Xu, Maria Celeridad, Jeff Lachowitzer, Brydon Bennett, Mehran Moghaddam, Oleg Khatsenko, Jason Katz, Rachel Fan, April Bai, Yang Tang, Michael A. Shirley, Brent Benish, Tracey Bodine, Kate Blease, Heather Raymon, Brian E. Cathers & Yoshitaka Satoh. (2012) Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor. Bioorganic & Medicinal Chemistry Letters 22:3, pages 1433-1438.
Crossref
Crossref
E. Krafft, H.P. Heikkilä, P. Jespers, D. Peeters, M.J Day, M.M. Rajamäki, K. Mc Entee & C. Clercx. (2011) Serum and Bronchoalveolar Lavage Fluid Endothelin-1 Concentrations as Diagnostic Biomarkers of Canine Idiopathic Pulmonary Fibrosis. Journal of Veterinary Internal Medicine 25:5, pages 990-996.
Crossref
Crossref